晚期结直肠癌-话题@MedSci

#晚期结直肠癌#

32篇内容 | 1919人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2164191, encodeId=1d6f216419109, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>浸润预测免疫检查点抑制剂治疗<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>的优势人群, objectTitle=读书报告 | 淋巴细胞浸润预测免疫检查点抑制剂治疗晚期结直肠癌的优势人群, objectType=article, longId=796744, objectId=3928e967447b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=3928e967447b, replyNumber=0, likeNumber=127, createdTime=2023-10-22, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3928e967447b, moduleTitle=读书报告 | 淋巴细胞浸润预测免疫检查点抑制剂治疗晚期结直肠癌的优势人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3928e967447b)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1985971, encodeId=f6e319859e124, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=Folfoxiri方案在晚期结直肠癌中的应用, objectType=article, longId=220899, objectId=383422089922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=383422089922, replyNumber=0, likeNumber=74, createdTime=2022-07-30, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=383422089922, moduleTitle=Folfoxiri方案在晚期结直肠癌中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=383422089922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985974, encodeId=da9e19859e44f, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！, objectType=article, longId=221421, objectId=c3fc22142171, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3fc22142171, replyNumber=0, likeNumber=97, createdTime=2022-08-13, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3fc22142171, moduleTitle=JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3fc22142171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985973, encodeId=141b19859e304, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=等效优质，经济可及——安可达为中国晚期结直肠癌患者带来福音, objectType=article, longId=221125, objectId=5a2122112569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a2122112569, replyNumber=0, likeNumber=81, createdTime=2022-01-09, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a2122112569, moduleTitle=等效优质，经济可及——安可达为中国晚期结直肠癌患者带来福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a2122112569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985972, encodeId=651919859e24a, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=三药联合方案治疗晚期结直肠癌的效果, objectType=article, longId=220901, objectId=f96d2209012c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96d2209012c, replyNumber=0, likeNumber=68, createdTime=2022-01-27, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96d2209012c, moduleTitle=三药联合方案治疗晚期结直肠癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f96d2209012c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985969, encodeId=2fd61985969f1, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比, objectType=article, longId=218080, objectId=e0d821808039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d821808039, replyNumber=0, likeNumber=79, createdTime=2021-11-24, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d821808039, moduleTitle=The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0d821808039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985970, encodeId=7af119859e08f, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察, objectType=article, longId=220892, objectId=769f22089252, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769f22089252, replyNumber=0, likeNumber=74, createdTime=2022-05-09, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769f22089252, moduleTitle=西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=769f22089252)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985968, encodeId=25e9198596866, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=Clin Cancer Res：瑞戈非尼联合奥维单抗治疗微卫星稳定的晚期结直肠癌, objectType=article, longId=210533, objectId=7994210533f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7994210533f7, replyNumber=0, likeNumber=94, createdTime=2021-11-21, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7994210533f7, moduleTitle=Clin Cancer Res：瑞戈非尼联合奥维单抗治疗微卫星稳定的晚期结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7994210533f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985967, encodeId=ed79198596ea4, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=JCO：化疗加上原发性肿瘤切除并不能提升晚期结直肠癌患者的疗效, objectType=article, longId=207044, objectId=158c20e0442d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=158c20e0442d, replyNumber=0, likeNumber=87, createdTime=2021-07-23, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=158c20e0442d, moduleTitle=JCO：化疗加上原发性肿瘤切除并不能提升晚期结直肠癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=158c20e0442d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985966, encodeId=37ea19859668b, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=Clin Cancer Res：基于智能分析的基因特征可预测采用奥沙利铂一线化疗的晚期结直肠癌预后, objectType=article, longId=205907, objectId=246f20590eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=246f20590eea, replyNumber=0, likeNumber=86, createdTime=2021-09-18, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=246f20590eea, moduleTitle=Clin Cancer Res：基于智能分析的基因特征可预测采用奥沙利铂一线化疗的晚期结直肠癌预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=246f20590eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985964, encodeId=d8b3198596428, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=Br J Cancer：FOLFIRI治疗方案与西妥昔单抗或贝伐单抗联合治疗晚期结直肠癌的FIRE-3 3期随机临床研究, objectType=article, longId=203464, objectId=b4f620346485, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f620346485, replyNumber=0, likeNumber=96, createdTime=2020-12-03, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f620346485, moduleTitle=Br J Cancer：FOLFIRI治疗方案与西妥昔单抗或贝伐单抗联合治疗晚期结直肠癌的FIRE-3 3期随机临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f620346485)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985963, encodeId=087a198596354, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=2020 WCGIC 晚期结直肠癌研究解读, objectType=article, longId=198157, objectId=5a0819815e19, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a0819815e19, replyNumber=0, likeNumber=88, createdTime=2020-07-29, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a0819815e19, moduleTitle=2020 WCGIC 晚期结直肠癌研究解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a0819815e19)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985965, encodeId=a68519859655c, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=NEJM：派姆单抗用于治疗微卫星高度不稳定性晚期结直肠癌, objectType=article, longId=204082, objectId=086920408244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=086920408244, replyNumber=0, likeNumber=65, createdTime=2021-09-27, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=086920408244, moduleTitle=NEJM：派姆单抗用于治疗微卫星高度不稳定性晚期结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=086920408244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985962, encodeId=f6aa198596213, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=Boehringer收购AMAL公司，获得其针对晚期结直肠癌的肿瘤疫苗, objectType=article, longId=175749, objectId=dff21e5749a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dff21e5749a6, replyNumber=0, likeNumber=80, createdTime=2020-03-11, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dff21e5749a6, moduleTitle=Boehringer收购AMAL公司，获得其针对晚期结直肠癌的肿瘤疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dff21e5749a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985961, encodeId=ca5f1985961a8, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=JAMA：高剂量维生素D对晚期结直肠癌患者有益, objectType=article, longId=164142, objectId=09951641428b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09951641428b, replyNumber=0, likeNumber=92, createdTime=2019-10-17, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09951641428b, moduleTitle=JAMA：高剂量维生素D对晚期结直肠癌患者有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09951641428b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985960, encodeId=db02198596024, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=微芯生物与信达生物宣布合作开展晚期结直肠癌联合治疗的临床评估, objectType=article, longId=160430, objectId=d8d71604300d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8d71604300d, replyNumber=0, likeNumber=70, createdTime=2019-12-07, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8d71604300d, moduleTitle=微芯生物与信达生物宣布合作开展晚期结直肠癌联合治疗的临床评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8d71604300d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985959, encodeId=1e62198595978, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=妊娠合并晚期结直肠癌肝转移病例分享, objectType=article, longId=150836, objectId=912915083687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=912915083687, replyNumber=0, likeNumber=84, createdTime=2019-07-22, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=912915083687, moduleTitle=妊娠合并晚期结直肠癌肝转移病例分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=912915083687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985957, encodeId=904f198595e94, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？, objectType=article, longId=144329, objectId=fcb514432948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcb514432948, replyNumber=0, likeNumber=92, createdTime=2018-10-13, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcb514432948, moduleTitle=J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcb514432948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985958, encodeId=2839198595805, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=ANN ONCOL：替莫唑胺联合伊立替康治疗携带MGMT甲基化的晚期结直肠癌患者, objectType=article, longId=147481, objectId=341014e4818d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=341014e4818d, replyNumber=0, likeNumber=0, createdTime=2018-09-17, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=341014e4818d, moduleTitle=ANN ONCOL：替莫唑胺联合伊立替康治疗携带MGMT甲基化的晚期结直肠癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=341014e4818d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985956, encodeId=61b919859569f, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=DNA疫苗治疗晚期结直肠癌, objectType=article, longId=139365, objectId=65d61393656d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65d61393656d, replyNumber=0, likeNumber=107, createdTime=2019-05-10, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65d61393656d, moduleTitle=DNA疫苗治疗晚期结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65d61393656d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期结直肠癌

2020-05-29

(审核中...)

前往app查看评论内容

#淋巴细胞#浸润预测免疫检查点抑制剂治疗#晚期结直肠癌#的优势人群

读书报告 | 淋巴细胞浸润预测免疫检查点抑制剂治疗晚期结直肠癌的优势人群

2023-10-22发表于上海

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

Folfoxiri方案在晚期结直肠癌中的应用

2022-07-30

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！

2022-08-13

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

等效优质，经济可及——安可达为中国晚期结直肠癌患者带来福音

2022-01-09

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

三药联合方案治疗晚期结直肠癌的效果

2022-01-27

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比

2021-11-24

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察

2022-05-09

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

Clin Cancer Res：瑞戈非尼联合奥维单抗治疗微卫星稳定的晚期结直肠癌

2021-11-21

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

JCO：化疗加上原发性肿瘤切除并不能提升晚期结直肠癌患者的疗效

2021-07-23

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

Clin Cancer Res：基于智能分析的基因特征可预测采用奥沙利铂一线化疗的晚期结直肠癌预后

2021-09-18

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

Br J Cancer：FOLFIRI治疗方案与西妥昔单抗或贝伐单抗联合治疗晚期结直肠癌的FIRE-3 3期随机临床研究

2020-12-03

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

2020 WCGIC 晚期结直肠癌研究解读

2020-07-29

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

NEJM：派姆单抗用于治疗微卫星高度不稳定性晚期结直肠癌

2021-09-27

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

Boehringer收购AMAL公司，获得其针对晚期结直肠癌的肿瘤疫苗

2020-03-11

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

JAMA：高剂量维生素D对晚期结直肠癌患者有益

2019-10-17

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

微芯生物与信达生物宣布合作开展晚期结直肠癌联合治疗的临床评估

2019-12-07

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

妊娠合并晚期结直肠癌肝转移病例分享

2019-07-22

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？

2018-10-13

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

ANN ONCOL：替莫唑胺联合伊立替康治疗携带MGMT甲基化的晚期结直肠癌患者

2018-09-17

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

DNA疫苗治疗晚期结直肠癌

2019-05-10

科室
- - 订阅+
  - 更多科室
工具
服务